Anxiety may hold key to depression treatment resistance

NCT ID NCT03690856

Ongoing Knowledge-focused Sponsor: Rennes University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study explores how anxiety contributes to treatment-resistant depression. Researchers will follow 37 adults with depression to see if anxiety levels can predict who will have a harder time recovering. The goal is to better identify at-risk patients and develop more targeted treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEPRESSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Depression depressive disorder major depressive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DEPRESSION

Contacts and locations

Locations

CH Guillaume Regnier

Rennes, 35000, France
CH Henri Laborit

Poitiers, 86021, France
CH Saint-Malo

St-Malo, 35400, France
CHU angers

Angers, 49933, France
CHU de Brest - Hôpital de Bohars

Brest, 29820, France
CHU de Nantes - Hotel-Dieu

Nantes, 44000, France
CHU de Tours, Clinique Psychiatrique Universitaire

Tours, 37044, France
EPSM du Morbihan

Saint-Avé, 56896, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.